Dr Kellen Gary Hipp, DO | |
9 Healthcare Dr Ste 202, Biddeford, ME 04005-9450 | |
(207) 283-1427 | |
Not Available |
Full Name | Dr Kellen Gary Hipp |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 9 Healthcare Dr Ste 202, Biddeford, Maine |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427406701 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | DO3387 (Maine) | Primary |
Entity Name | Mainehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
A team led by scientists at The Scripps Research Institute (TSRI) has identified key signaling proteins in the inflammation process that contribute to the development of inflammatory diseases such as rheumatoid arthritis, psoriasis, sepsis and inflammatory bowel diseases.
Research into intermittent preventive treatment of malaria in infants (IPTi) found that one-third of malaria cases in African babies can be prevented by giving them regular doses of malaria drugs even if they have not contracted the disease, according to a Lancet study, published on Thursday, Reuters reports. The study found that IPTi "helped children build better immunity to the disease and reduced the risk of the parasite becoming drug-resistant," but "these benefits decrease if treatment is given continuously as a prophylaxis," Reuters writes.
Adjustable-height chairs with ergonomically curved seats can significantly reduce neck and shoulder pain in garment workers, according to a new study in the April 20 issue of Spine.
Rhythm, a biopharmaceutical company, and Actavis plc, a leading global pharmaceutical company, announced today the initiation of a Phase 2b clinical trial assessing the efficacy and safety of relamorelin (RM-131), Rhythm's ghrelin agonist, for the treatment of gastroparesis in patients with type 1 and type 2 diabetes.
Patients taking inhaled corticosteroids are at increased risk of developing type 2 diabetes, and more so with higher doses, say researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research (LDI) In Montreal. The risk is of special concern for patients suffering from chronic obstructive pulmonary disorder (COPD), and much less significant for asthmatics.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kellen Gary Hipp, DO 22250 Providence Dr, Southfield, MI 48075-4825 Ph: (248) 849-3281 | Dr Kellen Gary Hipp, DO 9 Healthcare Dr Ste 202, Biddeford, ME 04005-9450 Ph: (207) 283-1427 |
News Archive
A team led by scientists at The Scripps Research Institute (TSRI) has identified key signaling proteins in the inflammation process that contribute to the development of inflammatory diseases such as rheumatoid arthritis, psoriasis, sepsis and inflammatory bowel diseases.
Research into intermittent preventive treatment of malaria in infants (IPTi) found that one-third of malaria cases in African babies can be prevented by giving them regular doses of malaria drugs even if they have not contracted the disease, according to a Lancet study, published on Thursday, Reuters reports. The study found that IPTi "helped children build better immunity to the disease and reduced the risk of the parasite becoming drug-resistant," but "these benefits decrease if treatment is given continuously as a prophylaxis," Reuters writes.
Adjustable-height chairs with ergonomically curved seats can significantly reduce neck and shoulder pain in garment workers, according to a new study in the April 20 issue of Spine.
Rhythm, a biopharmaceutical company, and Actavis plc, a leading global pharmaceutical company, announced today the initiation of a Phase 2b clinical trial assessing the efficacy and safety of relamorelin (RM-131), Rhythm's ghrelin agonist, for the treatment of gastroparesis in patients with type 1 and type 2 diabetes.
Patients taking inhaled corticosteroids are at increased risk of developing type 2 diabetes, and more so with higher doses, say researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research (LDI) In Montreal. The risk is of special concern for patients suffering from chronic obstructive pulmonary disorder (COPD), and much less significant for asthmatics.
› Verified 7 days ago
Dr. Peter G Kachavos, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 46 Barra Rd, Biddeford, ME 04005 Phone: 207-282-3349 | |
Jennifer Cutone, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 30 W Cole Rd, Biddeford, ME 04005 Phone: 207-282-3349 Fax: 207-282-6099 | |
Dr. Eva Zaslavsky, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 26 W Cole Rd, Biddeford, ME 04005 Phone: 207-294-5800 Fax: 207-294-5801 | |
Thomas Courtney, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2 Medical Center Dr, Suite 3, Biddeford, ME 04005 Phone: 207-283-8406 | |
Nadeem S Ali, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 30 West Cole Road, Biddeford, ME 04005 Phone: 207-282-3349 Fax: 207-282-6099 | |
Dr. Richard Martin Kahn, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Drive, Suite 209, Biddeford, ME 04005 Phone: 207-283-6408 Fax: 207-286-1327 | |
Christopher Patrick Blomberg, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Dr Ste 105, Biddeford, ME 04005 Phone: 207-282-3666 |